Shanghai - Delayed Quote CNY

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS)

18.64

-0.06

(-0.32%)

At close: 3:00:03 PM GMT+8

HUTCHMED to Divest 45% Equity Stake in Shanghai Hutchison Pharmaceuticals for $608 Million

HUTCHMED (HCM) said Wednesday it has agreed to sell a 45% equity interest in Shanghai Hutchison Phar

PREMIUM
MT Newswires 3 months ago

SHPMY
HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture

— HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize its portfolio and bring innovative medicines to patients globally — — Divestment proceeds to advance HUTCHMED’s pipeline and core innovative medicines business — — Focused R&D investment includes HUTCHMED’s proprietary antibody-targeted therapy conjugate platform, with first candidates expected to enter clinical trials in the second half of 2025 — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., J

GlobeNewswire 3 months ago

HCM

HMDCF

SHPMF

Performance Overview

Return	601607.SS	SSE Composite Index (000001.SS)
YTD	-11.24%	-3.39%
1-Year	+13.88%	+6.72%
3-Year	-1.52%	+2.24%